Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia.
Lappin
Terence R
TR
Centre for Cancer Research and Cell Biology, Queen's University, Belfast, Belfast City Hospital, Belfast BT9 7AB, Northern Ireland. t.lappin@qub.ac.uk
Maxwell
A Peter
AP
Johnston
Patrick G
PG
D000740:Anemia / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000401:mortality*; D011994:Recombinant Proteins; D012449:Safety; D016019:Survival Analysis
D006397:Hematinics; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa